Mass Tort & MDL Plaintiff Funding in Georgia

Georgia applies a two-year limitations period to a mass tort claim (O.C.G.A. §9-3-33), with the substantive product liability standard codified at O.C.G.A. §51-1-11. Georgia's 10-year statute of repose, running from the date of first sale for use or consumption (O.C.G.A. §51-1-11(b)(2)), is comparatively straightforward and does not carry the discovery-based exceptions some other states build in for latent-exposure mass torts, making the original sale date a critical early fact to establish for any Georgia mass tort claim involving an older product. Georgia enacted sweeping tort-reform legislation in its 2025 session; whether it altered any mass-tort- or product-liability-specific provision should be confirmed against the enrolled act.

Georgia applies modified comparative fault with a 50% bar (O.C.G.A. §51-12-33) to a strict-liability mass tort claim as well as a negligence claim, a framework typically built into a mass tort settlement matrix's point categories rather than litigated individually for each enrolled plaintiff.

Georgia has no general statutory cap on compensatory damages in a mass tort action; the Georgia Supreme Court struck down the state's medical-malpractice non-economic damages cap in Atlanta Oculoplastic Surgery, P.C. v. Nestlehutt, 286 Ga. 731 (2010), and this case type has no separate cap of its own.

Georgia does not award traditional pre-judgment interest on unliquidated personal-injury damages; Georgia's offer-of-settlement statute (O.C.G.A. §9-11-68) can instead impose fee-and-expense consequences on a party that rejects a reasonable settlement offer and fails to improve on it at trial.

A Georgia mass tort claim filed in or removable to federal court can be transferred to a federal MDL under 28 U.S.C. §1407 for coordinated pretrial proceedings. Georgia does not maintain a widely known dedicated state-level mass tort coordination program comparable to New Jersey's or Pennsylvania's, so a Georgia-filed mass tort claim not consolidated federally generally proceeds under ordinary Georgia civil procedure and venue rules (O.C.G.A. §9-10-31 for non-resident and multiple-defendant scenarios).

Georgia regulates consumer litigation funding under the Georgia Courts Access and Consumer Protection Act (SB 69), O.C.G.A. Title 7, Ch. 10, §§ 7-10-1 et seq.. No fixed percentage or APR cap.

Why does Georgia's straightforward 10-year repose period matter more for a mass tort involving an older product than in some other states?

Unlike states that build discovery-based exceptions into their repose statutes for latent-injury fact patterns, Georgia's 10-year period runs cleanly from the date of first sale, so a Georgia mass tort claim involving a product purchased more than a decade ago faces a real risk of being time-barred regardless of when the injury or its cause was actually discovered.

This makes establishing the original purchase or first-sale date an especially high-priority early diligence step for a Georgia mass tort claim — more so than in a state whose repose statute carries a discovery-based or concealment-based exception that could otherwise keep an older claim alive.

How does Georgia's 2025 tort-reform legislation create near-term uncertainty for a mass tort funding decision?

Georgia regulates consumer litigation funding under the Georgia Courts Access and Consumer Protection Act (SB 69), O.C.G.A. Title 7, Ch. 10, §§ 7-10-1 et seq. Signed 4/21/2025; most provisions effective 1/1/2026. No fixed percentage or APR cap. A financier's recovery is limited to a "proportional share" of proceeds rather than a numeric ceiling; financings of $25,000 or more can trigger joint-and-several liability for frivolous-litigation sanctions. Disclosure and conduct rules: Written agreement with required consumer disclosures; 5-day right to cancel without penalty; agreements of $25,000+ are discoverable in the underlying case; financiers must register with the Georgia Dept. of Banking and Finance via NMLS; foreign-government-affiliated financiers are barred.